School of Medicine
Showing 801-820 of 1,323 Results
-
Chun Yin Siu
Postdoctoral Scholar, Psychiatry
BioChunyin Siu (Alex) is a postdoctoral scholar in the Brain Dynamics Lab, led by Prof. Mannish Saggar, at the Stanford University School of Medicine. He specializes in topological data analysis and its application in analyzing neuroimaging data.
He got his PhD degree in Applied Mathematics at Cornell University under the supervision of Prof. Gennady Samorodnitsky. Before that, he got this MPhil. degree in Mathematics at the Chinese University of Hong Kong under the supervision of Prof. Ronald (Lokming) Lui. -
Shyam Mohan Sivasankar
Clinical Assistant Professor, Emergency Medicine
BioMy interests lie in the intersection of Medicine and Media, Global Pediatric Emergency Medicine Education, Child Abuse Pediatrics, and in Medical Student Education.
-
Alexandre Six
Postdoctoral Scholar, Pathology
BioMy research is grounded in my curiosity about the living world and my desire to contribute to impactful, concrete discoveries. I began my journey in the world of biotechnology and microalgae during my studies at UTC in France, where I grew Volvox algae for tissue engineering purposes. Since then, I have been interested in studying and developing the potential of microalgae. During my PhD at CEA Cadarache, I investigated starch production in green microalgae for use in bioplastics. This work involved studying the induction, physiology and light requirements of starch accumulation, as well as developing a bioprocess for starch extraction, purification and plasticization. Working with Yonghua Li-Beisson, I have generated mutant strains of Ostreococcus tauri, one of the smallest known eukaryotes, to study the evolution of lipid metabolism in algae and plants. Here at Stanford, I am developing a genetic toolbox for non-model cyanobacteria in the Yeh lab.
-
Shadt Skawratananond
Affiliate, Anesthesia - Adult Pain Medicine
Bio2026 FAER MSARF Fellow
-
Kelley M. Skeff, MD, PhD
George DeForest Barnett Professor of Medicine
Current Research and Scholarly InterestsDevelopment and evaluation of improved teaching methods; assessment of teacher's attitudes toward their teaching role; study of clinical teaching; evaluation of alternative methods of learning in clinical clerkships (e.g. computer assisted instruction, video tape review, etc.).
-
Eila C. Skinner
Thomas A. Stamey Research Professor of Urology
Current Research and Scholarly InterestsMy research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. I have also focused on optimizing the use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life.
-
Lawrie Skinner
Clinical Associate Professor, Radiation Oncology - Radiation Physics
BioLawrie Skinner, PhD DABR is a therapeutic medical physicist with clinical expertise in external beam radiation therapy, including advanced motion management techniques and MRI-guided radiation therapy.
Research interests generally revolve around developing novel devices for advanced clinical practice. Examples include personalized 3D printed electron beam collimators, rotating couch overlays for total body radiation therapy, and radiotransparent audio visual communication and immersion displays.
Dr skinner also has a research background in synchrotron x-ray scattering, neutron scattering, molecular dynamics and Monte Carlo computational modelling. -
Stephen Skirboll
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsMy research focuses on screening strategies to identify and characterize cancer stem cells (CSCs) in human gliomas. We are pursuing this in several ways: 1) a novel colony-forming antibody live cell array to identify distinct CSC surface phenotypes, 2) RNAi screens to identify kinases critical for CSC tumorigenicity, 3) high throughput small molecule and chemical screens to identify compounds that selectively kill or target CSCs, and 4) identifying CSCs using the tumor specific EGFRvIII
